Physician profile
Nora Breen
NPI 1184893067
$927.53
in general payments reported to CMS, 2019-2025
14 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.33 · 2022: $88.05 · 2023: $201 · 2024: $200 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $216.75 | 2022-2025 | Slynd |
| Astellas Pharma US INC | $167.09 | 2023-2025 | Veozah, Myrbetriq |
| Biogen, INC. | $104.01 | 2025 | Zurzuvae |
| Novo Nordisk INC | $88.46 | 2021-2025 | Wegovy |
| Sumitomo Pharma America, INC. | $60.74 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $60.19 | 2024-2025 | |
| Pfizer INC. | $48.77 | 2021-2024 | |
| Millicent US INC | $43.75 | 2025 | Femlyv |
| Organon LLC | $36.86 | 2022-2025 | Nexplanon |
| Sanofi Pasteur INC. | $22.76 | 2024 | |
| Therapeuticsmd, INC. | $22.06 | 2022 | |
| Mayne Pharma Commercial LLC | $20.40 | 2023 | |
| Ibsa Pharma INC. | $19.81 | 2024 | Licart, Tirosint |
| Abbvie INC. | $15.88 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nora Breen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.